Sequential cohort evaluation of ideal timing of imaging and treatment spacing to discern
maximal PSMA (Prostate specific membrane antigen) PET (Positron Emission Tomography) response
(PSMA-11 68Ga, Illucix) for adaptation of dominant intra-prostatic lesion tumor boost dose
Phase:
Phase 1
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborators:
Once Upon a Time Foundation Telix Pharmaceuticals (Innovations) Pty Limited